1. A randomized study on the usefulness of an electronic outpatient hypoglycemia risk calculator for clinicians of patients with diabetes in a safety-net institution. (2nd April 2020) Authors: Weiner, Michael; Cummins, Jonathan; Raji, Annaswamy; Ofner, Susan; Iglay, Kristy; Teal, Evgenia; Li, Xiaochun; Engel, Samuel S.; Knapp, Kristina; Rajpathak, Swapnil; Baker, Jarod; Chatterjee, Arnaub K.; Radican, Larry Journal: Current medical research and opinion Issue: Volume 36:Number 4(2020) Page Start: 583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adherence, persistence, and treatment discontinuation with sitagliptin compared with sulfonylureas as add‐ons to metformin: A retrospective cohort database study1: 在二甲双胍治疗的基础上比较加用西格列汀治疗与加用磺脲类药物治疗的依从性、持久性以及治疗中止:一项回顾性队列数据库研究. (7th October 2016) Authors: Bloomgarden, Zachary T.; Tunceli, Kaan; Liu, Jinan; Brodovicz, Kimberly G.; Mavros, Panagiotis; Engel, Samuel S.; Radican, Larry; Chen, Yong; Rajpathak, Swapnil; Qiu, Ying; Brudi, Philippe; Fonseca, Vivian Journal: Journal of diabetes Issue: Volume 9:Number 7(2017) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comorbidities in type 2 diabetes patients with and without atherosclerotic cardiovascular disease: a retrospective database analysis. (4th May 2021) Authors: Iglay, Kristy; Hannachi, Hakima; Engel, Samuel S.; Li, Xueying; O'Connell, David; Moore, Lori M.; Rajpathak, Swapnil Journal: Current medical research and opinion Issue: Volume 37:Number 5(2021) Page Start: 743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost‐effectiveness of intensification with sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes on metformin and sitagliptin vs direct intensification with insulin in the United Kingdom. Issue 4 (20th January 2019) Authors: Pawaskar, Manjiri; Bilir, S. Pinar; Kowal, Stacey; Gonzalez, Claudio; Rajpathak, Swapnil; Davies, Glenn Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 4(2019) Page Start: 1010 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Demographic and clinical profiles of type 2 diabetes mellitus patients initiating sitagliptin in the real-world setting. (3rd July 2017) Authors: Pawaskar, Manjiri; Liu, Jinan; Rajpathak, Swapnil; Iglay, Kristy; Engel, Samuel S.; Hannachi, Hakima Journal: Current medical research and opinion Issue: Volume 33:Number 7(2017) Page Start: 1247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Description of anti-diabetic drug utilization pre- and post-formulary restriction of sitagliptin: findings from a national health plan. (3rd August 2015) Authors: Huang, Xingyue; Liu, Zhiwen; Shankar, Ravi R.; Rajpathak, Swapnil Journal: Current medical research and opinion Issue: Volume 31:Number 8(2015:Aug.) Page Start: 1495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Distance to glycemic goal at the time of treatment intensification in patients with type 2 diabetes mellitus failing metformin monotherapy in the United States. (3rd May 2020) Authors: Fernandes, Gail; Sawhney, Baanie; Hannachi, Hakima; Liu, Jinan; Wang, Tongtong; Fu, Alex Z.; Iglay, Kristy; McNeill, Annie; Rajpathak, Swapnil Journal: Current medical research and opinion Issue: Volume 36:Number 5(2020) Page Start: 741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dose distribution and up‐titration patterns of metformin monotherapy in patients with type 2 diabetes. Issue 1 (17th December 2019) Authors: Iglay, Kristy; Sawhney, Baanie; Fu, Alex Z.; Fernandes, Gail; Crutchlow, Michael F.; Rajpathak, Swapnil; Khunti, Kamlesh Journal: Endocrinology, diabetes & metabolism Issue: Volume 3:Issue 1(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Factors associated with switching from sulphonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United States. Issue 10 (6th July 2021) Authors: Tan, Xi; Yang, Lingfeng; Khunti, Kamlesh; Zhang, Ruya; Zhang, Ye; Rajpathak, Swapnil; Yu, Miao Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 10(2021) Page Start: 2251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Factors associated with the discontinuation of dipeptidyl peptidase-4 inhibitors (DPP-4is) after initiation of insulin. (3rd March 2020) Authors: Fernandes, Gail; Matos, Joana E.; Jaffe, Dena H.; Beyer, Grace; Yang, Lingfeng; Iglay, Kristy; Gantz, Ira; Rajpathak, Swapnil Journal: Current medical research and opinion Issue: Volume 36:Number 3(2020) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗